Shukra Pharmaceuticals Allots Equity Shares on Warrant Conversion
Shukra Pharmaceuticals Ltd 路 Others (Uncategorized) 路 07 Oct 2026, 12:12 am
Shukra Pharmaceuticals Allots Equity Shares on Warrant Conversion Shukra Pharmaceuticals approved the allotment of 17,35,000 equity shares of Re.1/- each on 6th Oct'26 upon converting warrants held by promoter entities Ms. Anar Jayesh Patel and Anar Projects Private Limited. The allotment follows receipt of the 75% balance exercise price at Rs.26.67 per warrant, aggregating Rs.4.63 cr. Consequently, paid-up equity capital increased to Rs.44.25 cr (44,25,22,440 shares), with the combined promoter entities' holding rising from 19.70% to 20.01%. All 46,43,000 warrants allotted on 28th Jan'26 are fully converted, leaving zero outstanding warrants.
Original exchange filing (PDF)
More announcements from Shukra Pharmaceuticals Ltd
- Approval for Change of Name of Company on National Stock Exchange Limited dated 16th November 2026 路 17 Nov 2026
- Media Release 路 05 Nov 2026
- Shukra Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
- Reg 32 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- Unaudited financial results for the quarter ended 30th September 2026 路 05 Nov 2026
- SHUKRA PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 04 Nov 2026
- The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 The Board Meeting to be held on 03/11/2026 has been revised to 04/11/2026 路 04 Nov 2026
